Target intelligence / Profile preview

Prostaglandin E2 Receptor (PGE2 receptor)

Target
PGE2 receptor
Molecular classification
G protein-coupled receptor
01

Overview

The prostaglandin E2 receptor (PGE2 receptor) refers to a family of G protein-coupled receptors (GPCRs) that bind and are activated by prostaglandin E2, a key lipid mediator involved in numerous physiological and pathological processes. There are four main subtypes of PGE2 receptors, known as EP1, EP2, EP3, and EP4. Each subtype is encoded by a distinct gene and exhibits unique tissue distribution, signaling mechanisms, and biological functions. Targeting specific PGE² receptor subtypes offers potential for treating various conditions, including inflammatory diseases, cancer, and neurological disorders. Selective antagonists or agonists for these receptors are under investigation as next-generation anti-inflammatory or antiproliferative agents.

Other names
Prostaglandin E2 receptorsEP1 receptorEP2 receptorEP3 receptorEP4 receptorPTGER1PTGER2PTGER3PTGER4Prostaglandin E2 receptor 1Prostaglandin E2 receptor 2Prostaglandin E2 receptor 3Prostaglandin E2 receptor 4
02

Mechanism of action

G protein-coupled receptor signaling modulation

03

Biological functions

Regulation of inflammationModulation of immune cell functionControl of smooth muscle toneGastrointestinal mucosal protectionVascular homeostasisSignal transduction
04

Disease associations

Inflammatory diseasesCancerNeurological disordersGastrointestinal diseasesArthritis
05

Safety considerations

Potential for off-target effects due to multiple receptor subtypesComplexity of PGE2 signaling pathways leading to unpredictable outcomesTissue-specific effects of PGE2 receptor modulation requiring careful consideration

Beyond the preview

Go deeper on Prostaglandin E2 Receptor (PGE2 receptor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prostaglandin E2 Receptor (PGE2 receptor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call